today announced the following changes to its Board of Directors as part of its ongoing refreshment program: Following the 2025 Annual Meeting, the Board will be comprised of nine directors ...
Dynavax Technologies Corporation (Nasdaq: DVAX) (the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced the following changes ...